The FDA has approved the BLA for Ospomyv™ and Xbryk™, biosimilars to Prolia (denosumab) and Xgeva (denosumab), respectively.

The Tigers announced Friday that non-roster outfielder Akil Baddoo underwent surgery on Thursday to repair a fracture in his ...

Clear cell sarcoma is deemed highly aggressive due to its early tendency to metastasize, genetic mutations, and difficulty in ...

A fitness influencer was forced to have his have his lower jaw amputated after he was diagnosed with a rare form of oral ...

Celltrion today announced that the European Commission (EC) has granted marketing authorization for three products across two biosimilars: Eydenzelt® ...

"The best part of the job is hopefully curing somebody of cancer and giving them back the life they and their family wouldn’t ...

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will host a conference call on ...

Samsung Bioepis Co., Ltd. today announced that the European Commission (EC) has granted marketing authorization for OBODENCE™ (60mg pre-filled syringe) and XBRYK™ (120mg vial), denosumab biosimilars ...

SCID adalah Severe Combined Immunodeficiency alias kelainan genetik yang sangat langka. Kenali gejala, penyebab, hingga ...

A distal femoral resection was required due to bone necrosis and persistence of the sepsis after wide-spectrum antibiotics and debridements. A temporary cement spacer was placed, and control of the ...

Feb. 10, 2025 — When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response in the region changes, researchers report. The ...